Table 1.

Characteristics of the three DAs

	DA 1	DA 2	DA 3
Implementation period	July 2013–July 2014	March 2014–March 2016	August 2014–June 2016
Number of hospitals	8	16	8
Number of DAs distributed	284	273	351
Number of patients evaluating DA	255	183	235
DA format	Print booklet	Print booklet or online (by patient choice)	Online
Intended use	During consultation	Outside consultation	Outside consultation
DA content	General information about (treatment of) Pca is described first, then specific information on the procedures, the likelihood of cure and side effects in the urinary, and bowel and sexual domain for the each treatment is described. Risk information on the probabilities of progression, survival, and side effects (urinary, bowel and erectile) are presented by means of pie charts. No explicit values clarification exercises are included.	Treatment options are described in short terms. Arguments in favor and against each treatment are presented separately. Pros and cons that are presented include the following topics: cure, treatment, and quality of life. No explicit values clarification exercises are presented. An alphabetical glossary of difficult terminology is included, adjusted to low literacy. No values clarification exercises are included.	Elaborate information (text and graphics) about Pca and common terminology is provided. Active surveillance is compared with treatments, and in a next step, surgery is compared with radiation options. Advantages, disadvantages, and risks of each option are discussed. Risks are presented in a graphical display. VCEs are included as statements to trade off treatment attributes. A DA summary can be obtained for use during a follow-up consultation.